The “Global DNA and Gene Chip (Microarrays) Market (2010 – 2015)” analyzes the DNA microarray market by types and applications and studies the major market drivers, restraints, opportunities, and market trends for the DNA microarray market in North America, Europe, Asia, and Rest of the World.
Browse market data tables and in-depth TOC on Global DNA and Gene Chip (Microarrays) Market (2010 – 2015).
Early buyers will receive 10% customization of reports.
Microarrays were developed and commercialized in the eighties. Since then, market has offered tremendous growth and hence has seen an influx of players vying fiercely for a share or this market. The Global DNA & Gene Chip (microarray) market was valued at $760 million in 2010 and is expected to reach $1,425.2 million by 2015 growing at a CAGR of 13.4%. Major players in this market include Affymetrix, Inc. (U.S.), Illumnia, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), Roche NimbleGen (U.S.), Sequenom Inc, (U.S.), and others.
New product launches and agreements and collaborations are the two main strategies adopted by the players to stay competitive in this market. Although gene expression has been the dominant application of these chips, cancer diagnostics and treatment will lead the market in 2015 with a share of 24.2% as more and more companies invest in diagnostic chips since early detection of the disease and targeted treatment options are still the unmet need of this market. There were 12.3 million new cases of cancer worldwide in 2007 and about 7.6 million deaths. These figures are estimated to rise up to 16 million new cancer diagnoses cases and about 10 million deaths by 2020 according to WHO & American Cancer Society.
Scope of the report
This research report categorizes the Global DNA & Gene Chip (microarray) market on the basis of applications, types, and geography; forecasting revenues and analyzing trends in each of the following submarkets:
On the basis of applications
Gene Expression, cancer diagnostics & treatments, drug discovery, genetics (DNA sequencing by hybridization, reverse genetics, functional genomics and genomic mismatch scanning, gene mapping, diagnosis), SNP analysis, screening & monitoring of patient data during clinical trials, proteomics, toxicogenomics, microbial genotyping, agricultural biology, and environmental control.
On the basis of types
Oligonucleotide DNA Microarrays (oDNA) and Complementary DNA Microarrays (cDNA)
On the basis of geography
North America, Europe, Asia, and Rest of the World
MarketsandMarkets (M&M) is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world. MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services.
M&M covers thirteen industry verticals; including advanced materials, automotives and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository. To know more about us and our reports, please visit our website www.marketsandmarkets.com